Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Response to Pembrolizumab based on Progression Free Survival (PFS) to Ipilimumab
| Ipilimumab PFS | |||
|---|---|---|---|
| <90 days (n=57) | ≥90 days (n=59) | P value | |
| Objective Response Rate | 20 (35%) | 29 (49%) | 0.12 |
| Clinical Benefit Rate | 26 (46%) | 39 (66%) | 0.03 |
| <45 days (n=12) | ≥180 days (n=20) | ||
| Objective Response Rate | 3 (25%) | 11 (55%) | 0.09 |
| Clinical Benefit Rate | 3 (25%) | 16 (80%) | 0.002 |
